News | Coronavirus (COVID-19) | January 04, 2021| Dave Fornell, Editor

Who Qualifies for the COVID Vaccine Under CDC Guidelines

Who Can Get the COVID-19 Vaccine? Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, a nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, OTR/L, director of rehabilitation at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

The Centers for Disease Control and Prevention (CDC) Dec. 3, released an interim guidance document  to federal, state, and local jurisdictions on the allocation of initial doses of the COVID-19 vaccines. The document outlines who qualified for the first round of vaccinations with the Pfizer and Moderna vaccines. The priority order is given based on who is most at risk, those who are directly exposed to COVID carriers or patients on a daily bases and essential workers.

Phase 1a — Healthcare workers and Nursing Homes

   1. Healthcare personnel
   2. Residents of long-term care facilities (LTCFs)

Read the document The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020.

The report said about 21 million U.S. healthcare personnel work in settings such as hospitals, LTCFs, outpatient clinics, home healthcare, public health clinical services, emergency medical services and pharmacies. Healthcare personnel comprise clinical staff members, including nursing or medical assistants and support staff members (e.g., those who work in food, environmental and administrative services). Jurisdictions might consider first offering vaccine to healthcare personnel whose duties require proximity (within 6 feet) to other people. If vaccine supply remains constrained, additional factors might be considered for subprioritization. 

About 3 million adults reside in LTCFs, which include skilled nursing facilities, nursing homes and assisted living facilities. Depending upon the number of initial vaccine doses available, jurisdictions might consider first offering vaccination to residents and healthcare personnel in skilled nursing facilities because of high medical acuity and COVID-19–associated mortality among residents in these settings.

Phase 1b — Police, Firefighters and Essential Workers

   • Frontline essential workers such as fire fighters, police officers, corrections officers, food and agricultural workers, United States Postal Service workers, manufacturing workers, grocery store workers, public transit workers, and those who work in the educational sector, including teachers, support staff and daycare workers.

   • People aged 75 years and older, because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 75 years and older who are also residents of long-term care facilities should be offered vaccination in Phase 1a.

Phase 1c — People Aged 65 and Older, Other Essential Workers

   • People aged 65-74 years, because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 65-74 years who are also residents of long-term care facilities should be offered vaccination in Phase 1a.

   • People aged 16-64 years with underlying medical conditions that increase the risk of serious, life-threatening complications from COVID-19.

   • Other essential workers, such as people who work in transportation and logistics, food service, housing construction and finance, information technology, communications, energy, law, media, public safety, and public health.

Read more on the CDC vaccine prioritization plan.

 

Related COVID Content:

FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization

FDA Approved Second COVID-19 Vaccine From Moderna

COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent

VIDEO: Lingering Myocardial Involvement After COVID-19 Infection — Interview with Aaron Baggish, M.D.

 

COVID-19 Can Impact Hearts in Young Children

COVID-19 Positive STEMI Patients Have Higher Mortality 

VIDEO: ECMO Hemodynamic Support Effective in Sickest COVID-19 Patients — Interview with Ryan Barbaro, M.D.

The Cardiovascular Impact of COVID-19

 

COVID-19 Cardiovascular Registry Details Disparities Among Hospitalized Patients

VIDEO: How to Reduce COVID Exposure, Speed Exams and Cut Readmissions in Cardiology Departments— Interview with Keith Ellis, M.D.,

Find more cardiology related COVID content

Related Content

Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images

Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images

Feature | Coronavirus (COVID-19) | January 22, 2021 | Dave Fornell, Editor
With nearly a year of experience with the...
A recent Society for Cardiovascular Angiography and Interventions (SCAI) survey found nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus is still a risk. Survey respondents also said they are more afraid of catching the virus than they are of a heart attack or stroke, which may delay critical treatment. Getty Images

A recent Society for Cardiovascular Angiography and Interventions (SCAI) survey found nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus is still a risk. Survey respondents also said they are more afraid of catching the virus than they are of a heart attack or stroke, which may delay critical treatment. Getty Images

News | Coronavirus (COVID-19) | January 18, 2021
January 18, 2021 — According to a new national survey released Jan.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Myocarditis among recovering COVID-19 athletes appears to be less common than previously reported. Getty Images

News | Coronavirus (COVID-19) | January 12, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association (AHA) ...
The AHA and American Medical Society for Sports Medicine are collaborating to evaluate impact of COVID on the hearts of athletes, improve detection and inform safe return to play. #COVID19

The AHA and American Medical Society for Sports Medicine are collaborating to evaluate impact of COVID on the hearts of athletes, improve detection and inform safe return to play. Getty Images

News | Coronavirus (COVID-19) | January 12, 2021
January 12, 2021 — The American Heart Association (AHA) and the Ameri...
While the FDA said the risk that SARS-CoV-2 virus mutations will only have a minor impact on testing accuracy is low, the agency singled out three tests are they had a higher concern. FDA warns PCR tests may be innaccurate with new UK virus varient.

While the FDA said the risk that SARS-CoV-2 virus mutations will only have a minor impact on testing accuracy is low, the agency singled out three tests are they had a higher concern.

Feature | Coronavirus (COVID-19) | January 08, 2021 | Dave Fornell, Editor
January 8, 2021 — The U.S.
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.

Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al. 

Feature | Coronavirus (COVID-19) | December 23, 2020
December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulan
The FDA December 18 issued an emergency use authorization (EUA) for a second COVID-19 vaccine from Moderna for use in individuals 18 years of age and older. #COVID19 #SARSCoV2 #Vaccine

The FDA December 18 issued an emergency use authorization (EUA) for a second COVID-19 vaccine from Moderna for use in individuals 18 years of age and older.

News | Coronavirus (COVID-19) | December 23, 2020
December 23, 2020 — The U.S.
Coronavirus SARS-CoV-2 colorized scanning electron micrograph of a cell (pink) heavily infected with SARS-CoV-2 virus particles (teal and purple), isolated from a patient sample. Image courtesy of NIAID. MIS-C Multisystem inflammatory syndrome in children. #COVID19

Coronavirus SARS-CoV-2 colorized scanning electron micrograph of a cell (pink) heavily infected with SARS-CoV-2 virus particles (teal and purple), isolated from a patient sample. Image courtesy of NIAID.

News | Coronavirus (COVID-19) | December 22, 2020
December 22, 2020 — An observational study has launched to evaluate the short- and long-term health outcomes of SARS-
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine

The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec. 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance. 

Feature | Coronavirus (COVID-19) | December 14, 2020 | Dave Fornell, Editor
December 14, 2020 — The U.S.